Page last updated: 2024-11-01

niclosamide and Graft-Versus-Host Disease

niclosamide has been researched along with Graft-Versus-Host Disease in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morin, F1
Kavian, N1
Nicco, C1
Cerles, O1
Chéreau, C1
Batteux, F1

Other Studies

1 other study available for niclosamide and Graft-Versus-Host Disease

ArticleYear
Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
    The Journal of investigative dermatology, 2016, Volume: 136, Issue:11

    Topics: Animals; B-Lymphocytes; Cytokines; Disease Models, Animal; Flow Cytometry; Graft vs Host Disease; Im

2016